摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2,5-dimethyl-pyrrol-1-yl)-1,5-dimethyl-1H-pyrazole | 34605-65-7

中文名称
——
中文别名
——
英文名称
3-(2,5-dimethyl-pyrrol-1-yl)-1,5-dimethyl-1H-pyrazole
英文别名
3-(2,5-Dimethylpyrrol-1-yl)-1,5-dimethylpyrazole
3-(2,5-dimethyl-pyrrol-1-yl)-1,5-dimethyl-1<i>H</i>-pyrazole化学式
CAS
34605-65-7
化学式
C11H15N3
mdl
——
分子量
189.26
InChiKey
GOZBLIJWVVVOBO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    22.8
  • 氢给体数:
    0
  • 氢受体数:
    1

文献信息

  • PYRROLIDINONE GLUCOKINASE ACTIVATORS
    申请人:Berthel Steven Joseph
    公开号:US20090264445A1
    公开(公告)日:2009-10-22
    Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
    提供的化合物为公式(I): 以及药学上可接受的盐,其中取代基如说明书中所披露。这些化合物以及包含它们的药物组合物,可用于治疗代谢性疾病和障碍,例如,2型糖尿病。
  • PYRIDAZINONE GLUCOKINASE ACTIVATORS
    申请人:Berthel Steven Joseph
    公开号:US20090264434A1
    公开(公告)日:2009-10-22
    Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
    本文提供的是化合物的公式(I):以及其药学上可接受的盐,其中取代基如规范中所披露的那样。这些化合物及含有它们的药物组合物,对于治疗代谢性疾病和紊乱(例如2型糖尿病)是有用的。
  • TRICYCLIC COMPOUNDS
    申请人:Sarabu Ramakanth
    公开号:US20110313002A1
    公开(公告)日:2011-12-22
    The present invention provides novel compounds of formula I, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
    本发明提供了式I的新化合物,其中取代基如规范中所述。这些化合物及含有它们的药物组成物,可用于治疗代谢性疾病和疾病,例如II型糖尿病。
  • CHEMICAL COMPOUNDS
    申请人:SYNGENTA LIMITED
    公开号:US20160168126A1
    公开(公告)日:2016-06-16
    The invention relates to pyrrolone compounds of the formula (I) wherein X, R a , R b , R c , R 1 , R 2 and R 3 are as defined in the specification. Furthermore, the present invention relates to processes and intermediates for making compounds of formula (I), to herbicidal compositions comprising these compounds and to methods of using these compounds to control plant growth.
    本发明涉及式(I)的吡咯烷化合物,其中X、Ra、Rb、Rc、R1、R2和R3如规范中所定义。此外,本发明还涉及制备式(I)化合物的过程和中间体,包含这些化合物的除草剂组合物以及使用这些化合物控制植物生长的方法。
  • DIHYDRO-HYDANTOIN DERIVATIVES WITH HERBICIDAL ACTIVITY
    申请人:SYNGENTA PARTICIPATIONS AG
    公开号:US20160318906A1
    公开(公告)日:2016-11-03
    The invention relates to substituted dihydro-hydantoin derivatives of the formula (I) wherein X, R a , R b , R c , R 1 , R 2 and R 3 are as defined in the specification. Furthermore, the present invention relates to processes and intermediates for making compounds of formula (I), to herbicidal compositions comprising these compounds and to methods of using these compounds 10 to control or inhibit plant growth.
查看更多